Related Experiment Video
Updated: Feb 3, 2026

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.9K
Mutations of FAM111B gene are not associated with Systemic Sclerosis
A Gcelu1, G Deshpande2, G Shaboodien2
1Division of Rheumatology, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.
Scientific Reports
|October 31, 2018
Summary
Genetic analysis of the FAM111B gene in Systemic sclerosis (SSc) patients revealed no significant mutations. This study found no association between FAM111B gene mutations and SSc in the studied cohort.
Area of Science:
- Genetics
- Rheumatology
- Fibrotic Diseases
Background:
- Systemic sclerosis (SSc) is a fibrotic disease with an unclear genetic basis.
- Mutations in FAM111B cause a similar fibrotic condition, suggesting FAM111B as a candidate gene for SSc.
Purpose of the Study:
- To investigate the association between FAM111B gene mutations and Systemic sclerosis (SSc).
Main Methods:
- DNA analysis of 131 SSc patients using High-Resolution Melt and Sanger sequencing.
- Comparison of identified variants with ethnically-matched controls and public databases (1000 Genomes, ExAC).
Main Results:
- Two FAM111B variants were identified: one missense variant of unknown significance and one known polymorphism.
- The rare variant found in an SSc patient had no functional impact on the FAM111B gene.
Conclusions:
- FAM111B gene mutations are not associated with Systemic sclerosis (SSc) in this South African cohort.
- The study did not find evidence to support FAM111B as a causative gene for SSc.
Related Concept Videos
Mutation, Gene Flow, and Genetic Drift
64.3K
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.3K
Mutations
94.5K
Overview
94.5K
Mutations
44.5K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.5K
Viral Mutations
39.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Gene Flow
37.8K
Gene flow is the transfer of genes among populations, resulting from either the dispersal of gametes or from the migration of individuals.
37.8K

